These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12546859)

  • 1. Catalytic antioxidants prevent type 1 diabetes.
    Habeck M
    Drug Discov Today; 2002 Sep; 7(18):933-4. PubMed ID: 12546859
    [No Abstract]   [Full Text] [Related]  

  • 2. Metalloporphyrin class of therapeutic catalytic antioxidants.
    Patel M; Day BJ
    Trends Pharmacol Sci; 1999 Sep; 20(9):359-64. PubMed ID: 10462758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of airway inflammation and hyperreactivity by a catalytic antioxidant.
    Chang LY; Crapo JD
    Chest; 2003 Mar; 123(3 Suppl):446S. PubMed ID: 12629031
    [No Abstract]   [Full Text] [Related]  

  • 4. A salen-manganese catalytic free radical scavenger inhibits type 1 diabetes and islet allograft rejection.
    Olcott AP; Tocco G; Tian J; Zekzer D; Fukuto J; Ignarro L; Kaufman DL
    Diabetes; 2004 Oct; 53(10):2574-80. PubMed ID: 15448086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syngeneic islets transplanted into the thymus of newborn mice prevent diabetes and reduce insulitis in the NOD mouse.
    Nomura Y; Mullen Y; Stein E
    Transplant Proc; 1993 Feb; 25(1 Pt 2):963-4. PubMed ID: 8442281
    [No Abstract]   [Full Text] [Related]  

  • 6. Catalytic antioxidants to treat amyotropic lateral sclerosis.
    Crow JP
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1383-93. PubMed ID: 17040198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating diabetes complications by 1-Fe, a corrole-based catalytic antioxidant.
    Haber A; Angel I; Mahammed A; Gross Z
    J Diabetes Complications; 2013; 27(4):316-21. PubMed ID: 23602197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerogenic strategies to halt or prevent type 1 diabetes.
    Cooke A; Phillips JM; Parish NM
    Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metalloporphyrins as therapeutic catalytic oxidoreductants in central nervous system disorders.
    Sheng H; Chaparro RE; Sasaki T; Izutsu M; Pearlstein RD; Tovmasyan A; Warner DS
    Antioxid Redox Signal; 2014 May; 20(15):2437-64. PubMed ID: 23706004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
    Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
    Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of type I diabetes and recurrent beta-cell destruction of transplanted islets.
    Slover RH; Eisenbarth GS
    Endocr Rev; 1997 Apr; 18(2):241-58. PubMed ID: 9101139
    [No Abstract]   [Full Text] [Related]  

  • 12. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice.
    Heineke EW; Johnson MB; Dillberger JE; Robinson KM
    Diabetes; 1993 Dec; 42(12):1721-30. PubMed ID: 8243818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of type I diabetes in NOD mice by linomide.
    Slavin S; Gross D; Weiss L
    Transplant Proc; 1995 Dec; 27(6):3240. PubMed ID: 8539933
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose dependence of bacillus Calmette-Guerin on the prevention of autoimmune diabetes in syngeneic islet transplantation.
    Lakey JR; Singh B; Warnock GL; Elliott JF; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3413. PubMed ID: 8540025
    [No Abstract]   [Full Text] [Related]  

  • 16. BB islets transplanted ectopically to the kidney or thymus prevent progression to diabetes from autoimmunity in BB rats.
    Shinagawa Y; Brayman K; Field J; Farney A; Najarian J; Sutherland D
    Transplant Proc; 1994 Apr; 26(2):739. PubMed ID: 8171635
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus immunoregulatory genes and their cellular targets.
    Horwitz MS
    Virology; 2001 Jan; 279(1):1-8. PubMed ID: 11145883
    [No Abstract]   [Full Text] [Related]  

  • 19. Antioxidant therapy for the prevention of type I diabetes.
    Heller B; Burkart V; Lampeter E; Kolb H
    Adv Pharmacol; 1997; 38():629-38. PubMed ID: 8895827
    [No Abstract]   [Full Text] [Related]  

  • 20. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
    Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
    Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.